Bifeprunox Mesylate

More efficient, faster and cheaper. Ace Therapeutics are trustworthy.

sale

Bifeprunox Mesylate

Specification
Cat. No.
SMD1440
Related Diseases
Schizophrenia
Product Name
Bifeprunox Mesylate
Size
5.0mg; 10.0mg; 25.0mg
Price
Inquiry
Availability
2 Weeks
Description
Bifeprunox, also known as DU-127090, is a partial dopamine and serotonin agonist potentially for the treatment of schizophrenia. Bifeprunox influences nicotine-seeking behaviour in response to drug-associated stimuli in rats. Bifeprunox suppresses in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation.
CAS Number
350992-13-1 (mesylate)
Chemical Formula
C25H27N3O5S
Molecular Weight
481.567
Elemental Analysis
C, 62.35; H, 5.65; N, 8.73; O, 16.61; S, 6.66
Synonym
Bifeprunox; Bifeprunox Mesylate; DU-127090; DU 127090; DU127090.
IUPAC/Chemical Name
7-(4-(Biphenyl-3-ylmethyl)piperazin-1-yl)benzoxazol-2(3H)-one methanesulfonate
InChi Key
ONWKHSGOYGLGPO-UHFFFAOYSA-N
InChi Code
InChI=1S/C24H23N3O2.CH4O3S/c28-24-25-21-10-5-11-22(23(21)29-24)27-14-12-26(13-15-27)17-18-6-4-9-20(16-18)19-7-2-1-3-8-19;1-5(2,3)4/h1-11,16H,12-15,17H2,(H,25,28);1H3,(H,2,3,4)
SMILES Code
O=C1OC2=C(N3CCN(CC4=CC(C5=CC=CC=C5)=CC=C4)CC3)C=CC=C2N1.CS(=O)(O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4℃ for short term (days to weeks), or -20℃ for long term (months).
HS Tariff Code
2934.99.9001
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Enter Your Email to Subscribe

Enter your E-mail and receive the latest news from us

Copyright © Ace Therapeutics. All Rights Reserved.
Top